A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib

NCT01324596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1132

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

DRUG: Intravenous
DRUG: Bortezomib

Sponsor

University Hospital Southampton NHS Foundation Trust

Collaborators

[object Object]